| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |